The FDA extended its review of relutrigine for SCN2A- and SCN8A-related epilepsies by three months, pushing the PDUFA date to December 27, 2026.
|Articles|September 29, 2020
Dash For Dravet on Turkey Day
Author(s)NeurologyLive® Staff
Learn more about the 2020 Dash For Dravet, hosted by the Dravet Syndrome Foundation.
Advertisement
This content was courtest of the Dravet Syndrome Foundation. To view the original post, click
Before the feast, get your family and friends together for our ~ 5th annual ~ Dash for Dravet on Turkey Day!
This is a virtual 5K so it can be accomplished anywhere in the United States before, on or after Thanksgiving!
Run, walk, jog, roll or treadmill at your pace - there is no time limit.
Burn off calories before the big meal!
Registration is $25 per person
Raise funds on your personal fundraising page and DSF will send you the following:
- Raise $250 - choose between our purple/white scarf or a pair of our Turkey Trot Socks
- Raise $350 - receive our silver butterfly charm on a black cord (can be worn on a pandora bracelet as well)
- Raise $500 or more - receive a Yeti Rambler 12 ounce bottle
Why participate? Why donate?
- Proceeds benefit the Dravet Syndrome Foundation
whose mission is to raise money for research into Dravet Syndrome
and related childhood epilepsies while helping afflicted individuals and their families.
Advertisement
Related to this article
MS Compass: Guiding Clinical Care, a podcast hosted by neuroimmunologist Lindsay Ross, MD, brings you an exclusive interview with Rachel Galioto, PhD. [LISTEN TIME: 33 minutes]
The FDA lifted a clinical hold on simufilam, clearing Filana Therapeutics, formerly Cassava Sciences, to begin a phase 2a study in TSC-related epilepsy.
Xenon Pharmaceuticals submitted an FDA new drug application for azetukalner, a KV7 potassium channel opener, as adjunctive therapy for focal seizures in epilepsy.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
Brian Lin, PhD, discussed the current evidence linking football participation with ALS, the questions that remain unanswered, and how emerging research may help clarify the association.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Jennifer Fokas, MD, and Minali Nigam, MD. [LISTEN TIME: 21 minutes]
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Azetukalner NDA Submitted, EMA Gives Approval Recommendation to Ocrelizumab, Phase 3 FUSION Trial Meets End Points
2
What's Next in Ataxia: Pipeline Overview of Investigational Therapeutics
3
SKY-0515 Shows Sustained Benefit at 15 Months in Huntington Disease
4
FDA Extends Relutrigine Review, Delays PDUFA to December
5